Page 1603 - Small Animal Internal Medicine, 6th Edition
P. 1603
Index 1575
Sympathomimetic drugs (Continued) Tamsulosin, 733t–734t Thoracic radiography (Continued) Thromboembolism (Continued)
dosage of, 90t–91t Tapeworms, 487–488 pleural effusion, 360 in dogs
feline bronchitis treated with, 332 Target organs, 211 radiographs of, 288–295 clinical features of, 230–231
VetBooks.ir cardiovascular causes of, 3 Telogen defluxion, 748t vascular patterns of, 288–290, 289f, diagnosis of, 231
coagulation tests for, 231
Syncope
torsion of, 294–295
Taurine, 151, 170–171
Temporal muscle atrophy, 1223f
causes of, 2b
289b
diseases associated with, 230–233
heart failure and, 1–3
Tension pneumothorax, 376
peritoneopericardial diaphragmatic
test for, 2–3 Tenesmus, 403–404, 403b, 1001 Paragonimus kellicotti of, 345 echocardiographic findings, 231
physical examination findings,
Synovial fluid Terbinafine, 386t–388t, 472, 1504t hernia, 174–175 231
collection and analysis of Terbutaline sulfate, 386t–388t, pulmonary hypertension with shunt prognosis for, 231–232
arthrocentesis for, 1189, 1034t–1036t reversal, 115 prophylaxis against, 232–233
1190f–1191f in cats, 90t–91t, 327b pyothorax, 371 radiographic findings, 231
collection methods, 1190, 1190f description of, 98 trachea, 287–288 thromboelastography for, 231
gross appearance, 1190–1192, 1192f in dogs, 90t–91t, 327b vascular ring anomalies on, 116 treatment of, 231–232
smear preparation, 1190, 1192f dosage of, 90t–91t ventrodorsal view of, 287 warfarin for, 232–233
culture of, 1193 uterine contractility suppression using, views of, 287 prophylaxis against, 230, 232–233
description of, 1188–1189, 1189t 962 Thoracocentesis, 366–367 caudal aortic, 1162–1163
Synovial membrane biopsy, 1193 Testes, canine, 996–997, 996f catheters for, 367 coronary artery, 231
Syringomyelia, 1155, 1155f Testicular neoplasia, 996–997, 996f–997f chylothorax treated with, 374 diagnosis of, 1405
Systemic arterial hypertension, 211–220 Testicular parenchyma, 1001f congestive heart failure treated with, diseases associated with, 223b
Systemic inflammatory response Testicular torsion, 991, 991f 129 endothelial damage, 221
syndrome (SIRS), 432, 475 Tetanus, 1181–1182, 1182f description of, 61 general considerations for, 221–224
Systemic lupus erythematosus Tetany indications for, 366 in glomerular disease, 684–685
antinuclear antibody test for, 1194, hypocalcemic, 928 pleural effusion treated with, 167, 360, hypercoagulability secondary to, 223
1205, 1217, 1248 puerperal, 975 366 in immune-mediated hemolytic
clinical features of, 1247 Tetracyclines, 386t–388t, 1437t–1439t pneumothorax treated with, 345 anemia, 1237
diagnosis of, 1194, 1247–1248 Tetralogy of Fallot spontaneous pneumothorax treated pathophysiology of, 222–224
etiology of, 1247 clinical features of, 114 with, 377 prevention of, 1237
lupus erythematosus test for, 1194, cyanosis caused by, 113–114 technique for, 367 pulmonary
1217, 1247 diagnosis of, 114 Thoracolumbar disk extrusion, 1138t, abnormalities associated with, 355b
polyarthritis caused by, 1204–1205 dog breeds affected by, 102t 1139–1141, 1140f, 1140t clinical features of, 355
signs of, 1248t etiology of, 113–114 Thoracoscopy, 312 computed tomography pulmonary
treatment of, 1248–1249 pathophysiology of, 113–114 with lung biopsy, 312 angiography of, 356
Systemic vasculitis, 1453 prognosis for, 114 Thoracotomy, 367 D-dimer measurements, 355
Systole, 8 treatment of, 114 exploratory, 373–374 description of, 194, 224, 354–356
Systolic anterior motion (SAM), 26 Tetraparesis, 1045t Thorazine. see Chlorpromazine diagnosis of, 355–356
Systolic clicks, 9 Tetraplegia, 1045t Three-dimensional echocardiography, 33 fibrinolytic agents for, 356
Systolic murmurs Theophylline, 386t–388t Thrombin, 221–222 heartworm disease as cause of,
in cats, 159 canine chronic bronchitis treated with, Thrombocytopenia 201–203, 224
description of, 9–11 327, 327b approach to, 1395–1396 pleural effusion caused by, 360
Systolic time intervals (STIs), 27 feline bronchitis treated with, 332 causes of, 1393, 1395b postadulticide, 201–203
idiopathic pulmonary fibrosis treated description of, 1278, 1345t prevention of, 356
T with, 351 diagnostic tests for, 1218t–1219t prognosis for, 356
T3. see Triiodothyronine Theriogenology, 935–952 drug-associated, 1395 selective angiography of, 356
T4. see Thyroxine definition of, 935 fever associated with, 1426t treatment of, 356
Tachyarrhythmias estrous cycle, 937–940, 938t. see also immune-mediated sequelae of, 221
atrial fibrillation. see Atrial fibrillation Estrous cycle; Estrus causes of, 1241t in spontaneous hyperadrenocorticism,
rapid irregular rhythms, 79 prebreeding consultation, 935–937 classification of, 1240 224
rapid regular rhythms, 79–80 Thiabendazole, 515t–517t clinical features of, 1240, 1242f Thrombolysis, 222
sinus tachycardia, 79–80 Thiacetarsamide, 200 description of, 1396–1397 Thrombolytic therapy, 227b
supraventricular Thiamine deficiency, 1078, 1115 diagnosis of, 1240–1244, 1248t Thrombosis, 1405, 1405f
acute therapy for, 80–82 Thiazide diuretics, 67 etiology of, 1240 portal vein, 233
algorithm for, 81f Thiobarbiturates, 49b feline, 1244 vena caval, 233
mechanisms of, 78 Thiopurine methyltransferase, 1223 immunosuppressive drugs for, 1243 venous, 233–234
oral therapy for, 80 Third-degree atrioventricular block, physical examination of, 1240, 1242f Thymomas, 1172
refractory, 80 43–44, 44f prognosis for, 1244 Thyroglobulin, 776b, 779
vagal maneuver for, 82 Third eyelid protrusion, 1091, 1091f supportive care for, 1243–1244 Thyroglobulin autoantibodies, 777,
supraventricular tachycardia, 80–82 Third heart sound, 9 treatment of, 1243 956
ventricular Thoracic auscultation, 7, 285–286 in lymphadenopathy, 1415 Thyroid adenomas, 800
acute therapy for, 82–84 Thoracic limb withdrawal reflex, 1049, spontaneous bleeding caused by, 1387 Thyroid carcinomas, 800
algorithm for, 83f 1050f Thrombocytosis, 1426t Thyroid gland
in Boxers, 148 Thoracic radiography. see also Thromboelastography, 224, 231, 355, disorders of, 767–805
chronic oral therapy for, 84 Radiography 1361, 1405f function tests, 774–779
description of, 82 arrhythmogenic right ventricular Thromboembolic disease, 221–239 antibody tests for lymphocytic
refractory, 83–84 cardiomyopathy, 171 Thromboembolism thyroiditis, 779
treatment of, 83f arterial thromboembolism evaluations, arterial baseline serum fT 4 concentration,
Tachycardia, 37 225 in cats, 224–230 776–777
atrial bacterial pneumonia findings, 343 anticoagulant therapy, 227b baseline serum thyroid-stimulating
causes of, 39 caval syndrome, 202 antiplatelet therapy, 227b, 228 hormone concentration,
management of, 82 chest tube placement verification azotemia associated with, 777–778, 778f
sustained, 42f using, 369 225–226 baseline serum triiodothyronine
atrioventricular reciprocating, 44–45 degenerative atrioventricular valve cardiomyopathy as cause of, 224, concentrations, 775–776, 776b
paroxysmal AV reciprocating, 80–82 disease, 122, 123f 224f breed variations, 781–782
ventricular dorsoventral views of, 287 causes of, 1405 drugs that affect, 780–781, 781t
acute therapy for, 82–84 feline bronchitis, 330 clinical features of, 224–225, 225f, factors that affect, 779–782
chronic oral therapy for, 84 general principles of, 287 226b overview of, 774–775, 775f–776f
electrocardiography of, 41 lower respiratory tract disorders, 286 diagnosis of, 225–226 thyroid stimulating hormone and
intermittent paroxysms of, 42f lungs echocardiographic findings, 225 thyrotropin-releasing hormone
lidocaine for, 82 alveolar pattern, 290–292, 291f, 291b heparin for, 227b, 228 stimulation tests, 778–779
polymorphic, 41 atelectasis, 294, 294f limb function after treatment for, variables that affect, 777t
treatment of, 82–84 bronchial pattern, 290, 290f, 290b, 229–230 idiopathic atrophy of, 767
Tachycardia-induced cardiomyopathy, 293f prognosis for, 226–230 Thyroid hormones
152 cavitary lesions, 294, 295f prophylaxis against, 230 autoantibodies, 769t, 776b
Tachypnea, 4 interstitial pattern, 292–293, 292f radiographic findings, 225 Greyhound levels of, 1363
Tachyzoites, 1520 lobes consolidation of, 293–294, thrombolytic therapy for, 227b secretion of, 774–775
Tagamet. see Cimetidine 294f treatment of, 226–230, 227b Thyroid mass, 802f